SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 13.365
NA - Nord America 1.204
AS - Asia 825
SA - Sud America 129
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 23
OC - Oceania 3
Totale 15.612
Nazione #
IT - Italia 13.019
US - Stati Uniti d'America 1.153
SG - Singapore 344
CN - Cina 226
VN - Vietnam 95
BR - Brasile 89
SE - Svezia 82
DE - Germania 54
FI - Finlandia 43
FR - Francia 40
GB - Regno Unito 34
IN - India 33
CA - Canada 32
HK - Hong Kong 23
NL - Olanda 21
KR - Corea 14
AT - Austria 13
BD - Bangladesh 13
PL - Polonia 12
IE - Irlanda 10
IQ - Iraq 10
MX - Messico 10
AR - Argentina 9
CO - Colombia 9
VE - Venezuela 9
EC - Ecuador 8
PH - Filippine 8
BE - Belgio 7
ES - Italia 7
ZA - Sudafrica 7
ID - Indonesia 6
IR - Iran 6
TR - Turchia 6
IL - Israele 5
JP - Giappone 5
PK - Pakistan 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
TH - Thailandia 4
AU - Australia 3
KE - Kenya 3
KG - Kirghizistan 3
UZ - Uzbekistan 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GA - Gabon 2
JM - Giamaica 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
RU - Federazione Russa 2
SV - El Salvador 2
UA - Ucraina 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.551
Città #
Cagliari 12.283
Uta 605
Singapore 206
Ashburn 187
San Jose 126
Dallas 82
Boardman 52
Council Bluffs 50
New York 48
Chandler 45
Los Angeles 44
Beijing 41
Nyköping 41
The Dalles 35
Fairfield 33
Helsinki 32
Ho Chi Minh City 30
Rome 28
Hanoi 25
Santa Clara 22
Hefei 20
Hong Kong 19
Munich 19
Shanghai 17
Seattle 16
Seoul 14
Amsterdam 13
Chicago 12
Houston 12
Lauterbourg 12
Orem 12
Boston 11
Guangzhou 11
Pune 11
Buffalo 10
Düsseldorf 10
Montreal 10
Shenzhen 10
São Paulo 10
Denver 9
San Diego 9
Warsaw 9
Dublin 8
Frankfurt am Main 8
Nuremberg 8
Redondo Beach 8
Wilmington 8
Haiphong 7
London 7
Woodbridge 7
Brooklyn 6
Cambridge 6
Stockholm 6
Toronto 6
Turku 6
Vienna 6
Columbus 5
Lappeenranta 5
Manchester 5
Menlo Park 5
Mexico City 5
Milan 5
Zhengzhou 5
Atlanta 4
Bexley 4
Charlotte 4
Chennai 4
Da Nang 4
Dong Ket 4
Johannesburg 4
La Maddalena 4
Medellín 4
Paris 4
Phoenix 4
Rio de Janeiro 4
Roubaix 4
Selargius 4
Bishkek 3
Brussels 3
Buenos Aires 3
Caracas 3
Karachi 3
Manila 3
Nairobi 3
Naples 3
Peristeri 3
Piscataway 3
Quito 3
Riyadh 3
San Francisco 3
Sassari 3
Sydney 3
Tashkent 3
Tianjin 3
Turin 3
Washington 3
Wuhan 3
Al Hillah 2
Alexandria 2
Baghdad 2
Totale 14.545
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.792
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.384
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.243
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.213
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.109
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 1.005
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 975
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 953
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 776
Uncovering key targets of success for immunotherapy in pancreatic cancer 739
BRCA-mutant pancreatic ductal adenocarcinoma 638
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 634
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 606
Role of neutrophil-to-lymphocyte ratio (NLR) in the outcome of NSCLC EGFR mutated 330
Early taxane exposure and neurotoxicity in breast cancer patients 245
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 228
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 219
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 156
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 132
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 119
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 116
Totale 15.612
Categoria #
all - tutte 24.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022788 0 0 0 25 40 78 38 73 63 79 143 249
2022/20232.515 188 345 306 175 170 191 126 211 186 306 186 125
2023/20242.107 94 62 70 114 172 353 344 148 113 150 250 237
2024/20256.641 1.978 2.253 558 560 293 431 251 32 64 77 45 99
2025/20262.180 178 151 150 184 157 160 464 218 137 198 129 54
2026/2027318 23 61 92 142 0 0 0 0 0 0 0 0
Totale 15.612